Category - Executive Moves

Executive Moves

Kaleido Biosciences names Daniel Menichella as president and CEO

Kaleido Biosciences (NASDAQ:KLDO) appointed Daniel Menichella as president and CEO, effective Oct. 13. Mr. Menichella will replace Alison Lawton, who is stepping down for personal reasons. Mr. Menichella is an...

October 1, 2020

Executive Moves

PharmaJet appoints Melissa Malhame as VP business development

Closely-held PharmaJet appointed Melissa Malhame as its VP of business development, where she will lead the company’s business development, sales, and marketing operations. “[Ms. Malhame’s] strategic business...

September 29, 2020

Executive Moves

Eric Cheng joins Altium Capital as a managing director

After 23 years in investment banking, Eric Cheng has joined Altium Capital Management, an investment firm based in New York focused on the healthcare industry. Mr. Cheng most recently was managing director and head of...

September 1, 2020

Executive Moves

Perimeter Medical Imaging names Aaron Davidson to its board

Perimeter Medical Imaging (TSXV:PINK) appointed Aaron Davidson, currently CFO and SVP of corporate development at Profound Medical (TSX-V:PRN; OTCQX:PRFMF), to its board of directors. “[Mr. Davidson’s] experience at...

August 26, 2020

Executive Moves

Kane Biotech appoints renowned wound care and biofilms expert, Dr. Gregory Schultz, as scientific advisor

Kane Biotech (TSX-V:KNE) appointed wound care and biofilms expert, Dr. Gregory Schultz, as a scientific advisor. Dr. Schultz is the director of the Institute for Wound Research and professor of obstetrics and gynecology...

August 12, 2020

Executive Moves

Pacific Biosciences names Christian Henry as president and CEO

Pacific Biosciences (NASDAQ:PACB) appointed Christian Henry as president and CEO, effective Sept. 14. Mr. Henry will replace Michael Hunkapiller, who will retire at the end of 2020. Current Pacific Biosciences board...

August 7, 2020

Executive Moves

Zenabis names Shai Altman as president and CEO

Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1. Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief facilities officer. Mr. Altman...

July 31, 2020

Executive Moves

Canaccord boosts healthcare investment banking team

Canaccord Genuity named Thomas O’Connor as managing director, co-head of U.S. healthcare investment banking, with long-time partners, Matt Steere and Eugene Rozelman, joining Mr. O’Connor as fellow co-heads of the U.S...

July 23, 2020

Executive Moves

Rhythm Pharma appoints Dr. David Meeker as CEO

Rhythm Pharmaceuticals (NASDAQ:RYTM) appointed its chairman, Dr. David Meeker as CEO, effective immediately. Dr. Meeker replaces interim president and CEO, Hunter Smith, who will continue in his role as CFO. Dr. Meeker...

July 20, 2020

Executive Moves

Sun BioPharma names Jennifer Simpson as president and CEO

Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the company’s executive chairman. Dr. Simpson has more than 25 years of...

July 17, 2020

Category - Executive Moves

Kaleido Biosciences names Daniel Menichella as president and CEO

PharmaJet appoints Melissa Malhame as VP business development

Eric Cheng joins Altium Capital as a managing director

Perimeter Medical Imaging names Aaron Davidson to its board

Kane Biotech appoints renowned wound care and biofilms expert, Dr. Gregory Schultz, as scientific advisor

Pacific Biosciences names Christian Henry as president and CEO

Zenabis names Shai Altman as president and CEO

Canaccord boosts healthcare investment banking team

Rhythm Pharma appoints Dr. David Meeker as CEO

Sun BioPharma names Jennifer Simpson as president and CEO

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter